High-Quality Delta Sleep Inducing Peptide Manufacturers & Service

Thinheal delivers Delta Sleep Inducing Peptide (CAS 62568-57-4) at a standard chromatographic purity ≥ 98.0%, with premium batches reaching ≥ 99.2% by analytical RP-HPLC. The impurity profile strictly restricts individual unidentified impurities to ≤ 0.1%, with total related substances (such as truncated sequences, D-Asp5 diastereomers, or deamidated derivatives) kept strictly under 1.0%. Every delivered shipment comes with full HPLC and MS analytical traces for internal QA sign-off.

We provide DSIP with both standard Trifluoroacetate (TFA) salt and physiological Acetate salt forms. While TFA is common in early-stage synthesis, cell-culture experiments and in vivo translational studies generally demand Acetate or Hydrochloride counter-ions to mitigate cytotoxicity. Thinheal uses specialized ion-exchange preparative chromatography to reduce residual TFA content below 0.1% or to undetectable levels upon request.

Tryptophan is susceptible to atmospheric oxidation and alkylation during cleavage from resin. Thinheal utilizes protective scavenger cocktails containing 1,2-ethanedithiol (EDT), triisopropylsilane (TIS), and water within TFA cleavage solutions under strict inert nitrogen sparging. Following cleavage, rotary evaporation and freeze-drying are performed under vacuum to prevent yellow-discoloration and kynurenine-like degradation products.

DSIP is lyophilized into an amorphous cake and sealed under inert argon or nitrogen gas inside pharmaceutical-grade USP Type I borosilicate glass vials with rubber butyl stoppers and flip-off caps. Shipments are packed in certified thermal insulated shippers with gel packs or dry ice to maintain 2°C to 8°C or -20°C throughout transport, ensuring total integrity upon arrival at your destination facility.

For catalog items and small development batches (10g to 500g), delivery times typically range between 2 to 3 weeks, inclusive of full analytical testing. Commercial campaigns from 1kg to multi-kilograms usually require 4 to 6 weeks, which incorporates synthesis scale-up, twin-column purification, multi-shelf lyophilization, and full QA release testing with stability monitoring.

Yes. In addition to catalog research grades, Thinheal operates as an integrated peptide CDMO. We offer custom synthesis routes, process optimization, analytical method validation, and technical documentation support designed to align with international regulatory frameworks including US FDA and European EMA requirements.